uniQure (QURE) Interest Expenses (2015 - 2026)
uniQure's (QURE) quarterly Interest Expenses came in at $14.0 million in Q1 2026, up 116.16% year-on-year from $6.5 million in Q1 2025, and up 674.34% quarter-over-quarter from $1.8 million in Q4 2025.
uniQure (QURE) Interest Expenses (2015 - 2026) Analysis & Trends
uniQure's Interest Expenses history runs 12 years deep, the most recent figure standing at $14.0 million for Q1 2026.
- On a quarterly basis, Interest Expenses rose 116.16% year-over-year to $14.0 million in Q1 2026; TTM through Mar 2026 was $45.6 million, a 737.08% increase from a year earlier, with the FY2025 full-year figure at $271.4 million, up 41.45% from the prior year.
- Interest Expenses improved to $14.0 million in Q1 2026 per QURE's latest filing, from $1.8 million in the prior quarter.
- Across five years, Interest Expenses topped out at $30.7 million in Q4 2023 and bottomed at -$44.3 million in Q4 2024.
- The 5-year median for Interest Expenses is $6.5 million (2025), against an average of $7.1 million.
- Across the five-year window, Interest Expenses surged 750.64% in 2023 and plunged 244.39% in 2024, its largest moves.
- Year by year, Interest Expenses stood at $3.6 million in 2022, then jumped by 750.64% to $30.7 million in 2023, then plunged by 244.39% to -$44.3 million in 2024, then surged by 104.09% to $1.8 million in 2025, then jumped by 674.34% to $14.0 million in 2026.
- Per Business Quant, the three latest QURE Interest Expenses figures stand at $14.0 million (Q1 2026), $1.8 million (Q4 2025), and $14.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | uniQure | 2.42 Bn | 2.42 Bn | 3.34 Mn | 14.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.03 Mn |
| Mar 31, 2026 | 14.03 Mn |
| Dec 31, 2025 | 1.81 Mn |
| Dec 31, 2025 | 1.81 Mn |
| Sep 30, 2025 | 14.20 Mn |
| Sep 30, 2025 | 14.20 Mn |
| Jun 30, 2025 | 15.59 Mn |
| Jun 30, 2025 | 15.59 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Mar 31, 2025 | 6.49 Mn |
| Dec 31, 2024 | -44.27 Mn |
| Dec 31, 2024 | -44.27 Mn |
| Sep 30, 2024 | 16.61 Mn |
| Sep 30, 2024 | 16.61 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Mar 31, 2024 | 16.10 Mn |
| Mar 31, 2024 | 16.10 Mn |
| Dec 31, 2023 | 30.66 Mn |
| Dec 31, 2023 | 30.66 Mn |